首页> 美国卫生研究院文献>other >Delayed globin synthesis leads to excess heme and the macrocytic anemia of Diamond Blackfan anemia and del(5q) myelodysplastic syndrome
【2h】

Delayed globin synthesis leads to excess heme and the macrocytic anemia of Diamond Blackfan anemia and del(5q) myelodysplastic syndrome

机译:珠蛋白合成延迟导致血红素过多和钻石黑范氏贫血和del(5q)骨髓增生异常综合症

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Diamond Blackfan anemia (DBA) and myelodysplastic syndrome (MDS) with isolated del(5q) are severe macrocytic anemias; although both are associated with impaired ribosome assembly, why the anemia occurs is not known. We cultured marrow cells from DBA (n = 3) and del(5q) MDS (n = 6) patients and determined how heme (a toxic chemical) and globin (a protein) are coordinated. We show that globin translation initiates slowly, whereas heme synthesis proceeds normally. This results in insufficient globin protein, excess heme and excess reactive oxygen species in early erythroid precursors, and CFU-E (colony-forming unit–erythroid)/proerythroblast cell death. The cells that can more rapidly and effectively export heme or can slow heme synthesis preferentially survive and appropriately mature. Consistent with these observations, treatment with 10 mM succinylacetone, a specific inhibitor of heme synthesis, improved the erythroid cell output of DBA and del(5q) MDS marrow cultures by 68 to 95% (P = 0.03 to 0.05), whereas the erythroid cell output of concurrent control marrow cultures decreased by 4 to 13%. Our studies demonstrate that erythropoiesis fails when heme exceeds globin. Our data further suggest that therapies that decrease heme synthesis (or facilitate heme export) could improve the red blood cell production of persons with DBA, del(5q) MDS, and perhaps other macrocytic anemias.
机译:单独的del(5q)伴有菱形Blackfan贫血(DBA)和骨髓增生异常综合症(MDS),是严重的巨细胞性贫血。尽管两者均与核糖体装配受损有关,但尚不清楚为什么会发生贫血。我们培养了DBA(n = 3)和del(5q)MDS(n = 6)患者的骨髓细胞,并确定了血红素(一种有毒化学物质)和血红蛋白(一种蛋白质)是如何协调的。我们显示,珠蛋白翻译启动缓慢,而血红素合成正常进行。这会导致早期红系前体中的珠蛋白不足,血红素过多和活性氧过剩,以及CFU-E(集落形成单位–红系)/成红细胞死亡。可以更快速有效地输出血红素或减慢血红素合成的细胞优先存活并适当成熟。与这些观察结果一致,用血红素合成的特异性抑制剂10 mM琥珀酰丙酮处理可将DBA和del(5q)MDS骨髓培养物中的类红细胞产量提高68%至95%(P = 0.03至0.05),而类红细胞同时进行的对照骨髓培养的产量下降了4%至13%。我们的研究表明,当血红素超过球蛋白时,红细胞生成失败。我们的数据进一步表明,减少血红素合成(或促进血红素输出)的疗法可改善患有DBA,del(5q)MDS以及其他大细胞性贫血的人的红细胞生产。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号